These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12730703)

  • 41. SOP conservative (medical and mechanical) treatment of erectile dysfunction.
    Porst H; Burnett A; Brock G; Ghanem H; Giuliano F; Glina S; Hellstrom W; Martin-Morales A; Salonia A; Sharlip I;
    J Sex Med; 2013 Jan; 10(1):130-71. PubMed ID: 23343170
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral and injectable medications for the treatment of erectile dysfunction.
    Carson CC
    Curr Urol Rep; 2000 Dec; 1(4):307-12. PubMed ID: 12084309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prospective comprehensive assessment of sexual function after retropubic non nerve sparing radical prostatectomy for localized prostate cancer.
    Trinchieri A; Nicola M; Masini F; Mangiarotti B
    Arch Ital Urol Androl; 2005 Dec; 77(4):219-23. PubMed ID: 16444937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Erectile dysfunction: an overview.
    Fabbri A; Aversa A; Isidori A
    Hum Reprod Update; 1997; 3(5):455-66. PubMed ID: 9528911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Apomorphine and erectile dysfunction].
    Tan DQ; Yao Y; Zhang J
    Zhonghua Nan Ke Xue; 2007 Sep; 13(9):818-21. PubMed ID: 17929561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erectile dysfunction.
    Yafi FA; Jenkins L; Albersen M; Corona G; Isidori AM; Goldfarb S; Maggi M; Nelson CJ; Parish S; Salonia A; Tan R; Mulhall JP; Hellstrom WJ
    Nat Rev Dis Primers; 2016 Feb; 2():16003. PubMed ID: 27188339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
    Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
    Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intracavernosal therapy: when oral agents fail.
    Nehra A
    Curr Urol Rep; 2001 Dec; 2(6):468-72. PubMed ID: 12084233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Yohimbine treatment of organic erectile dysfunction in a dose-escalation trial.
    Guay AT; Spark RF; Jacobson J; Murray FT; Geisser ME
    Int J Impot Res; 2002 Feb; 14(1):25-31. PubMed ID: 11896474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The management of erectile dysfunction following spinal cord injury.
    Padma-Nathan H; Kanellos A
    Semin Urol; 1992 May; 10(2):133-7. PubMed ID: 1378971
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of intracavernosal pharmacotherapy on self-esteem, performance anxiety and partnership in patients with chronic erectile dysfunction.
    Bähren W; Scherb W; Gall H; Beckert R; Holzki G
    Eur Urol; 1989; 16(3):175-80. PubMed ID: 2744052
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of intracavernosal injection therapy and the reasons of withdrawal from therapy in patients with erectile dysfunction in the era of PDE5 inhibitors.
    Sung HH; Ahn JS; Kim JJ; Choo SH; Han DH; Lee SW
    Andrology; 2014 Jan; 2(1):45-50. PubMed ID: 24194017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sublingual apomorphine for the treatment of erectile dysfunction.
    Mulhall JP
    Expert Opin Investig Drugs; 2002 Feb; 11(2):295-302. PubMed ID: 11829718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Erectile function and dysfunction.
    Jordan GH
    Postgrad Med; 1999 Feb; 105(2):131-4, 137-8, 143-4 passim. PubMed ID: 10026708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intracavernosal therapy for erectile failure--impact of treatment and reasons for drop-out and dissatisfaction.
    Purvis K; Egdetveit I; Christiansen E
    Int J Impot Res; 1999 Oct; 11(5):287-99. PubMed ID: 10553808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological aspects of erectile dysfunction.
    Thomas JA
    Jpn J Pharmacol; 2002 Jun; 89(2):101-12. PubMed ID: 12120751
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Erectile dysfunction].
    Isidori A; Aversa A; Fabbri A
    Recenti Prog Med; 1999; 90(7-8):396-402. PubMed ID: 10429521
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contextual approaches to the physiology and classification of erectile function, erectile dysfunction, and sexual arousal.
    Sachs BD
    Neurosci Biobehav Rev; 2000 Jul; 24(5):541-60. PubMed ID: 10880820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function.
    Mulhall JP; Slovick R; Hotaling J; Aviv N; Valenzuela R; Waters WB; Flanigan RC
    J Urol; 2002 Mar; 167(3):1371-5. PubMed ID: 11832735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of intraurethral liposomal and intracavernosal prostaglandin-E1 in the management of erectile dysfunction.
    Engelhardt PF; Plas E; Hübner WA; Pflüger H
    Br J Urol; 1998 Mar; 81(3):441-4. PubMed ID: 9523667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.